Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis  Philippe-Jean Bousquet, MD, Christophe Combescure, PhD, Jean-Michel Klossek, MD, Jean-Pierre Daurès, MD, Jean Bousquet, MD  Journal of Allergy and Clinical Immunology  Volume 123, Issue 6, Pages 1349-1354 (June 2009) DOI: 10.1016/j.jaci.2009.02.033 Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Flow chart. Journal of Allergy and Clinical Immunology 2009 123, 1349-1354DOI: (10.1016/j.jaci.2009.02.033) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Cumulative distribution of VAS score changes depending on RQLQ score and RTSS4 changes. Journal of Allergy and Clinical Immunology 2009 123, 1349-1354DOI: (10.1016/j.jaci.2009.02.033) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 ROC curves (left) and cost function (right) evaluating VAS score evolution depending on clinical improvement. 1, No clinical improvement versus a clinical improvement in RQLQ score, RTSS4, or both. 2, No clinical improvement or clinical improvement in RQLQ score or RTSS4 versus clinical improvement in both RQLQ score and RTSS4. Journal of Allergy and Clinical Immunology 2009 123, 1349-1354DOI: (10.1016/j.jaci.2009.02.033) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions